abstract |
FIELD: chemistry. n SUBSTANCE: invention relates to a novel compound of formula I-1, characterised by effects of thrombolysis, accepting free radicals and directed action on thrombus. Compound is a three-component conjugate formed by conjugation of thrombolytic oligopeptide, free radical acceptor and a peptide with directed action on thromb/antithrombotic oligopeptide by binder link. n EFFECT: present invention also relates to a pharmaceutical composition containing compounds, wherein compounds form a nanospherical structure. n 13 cl, 40 dwg, 21 tbl, 17 ex |